SCHEMBL3595846

SCHEMBL3595846

COCC(C)Oc1cc(Oc2cc(F)cc(F)c2)cc(C(=O)O)c1

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.67
RARG P13631 1/20 0.67
RARA P10276 1/20 0.45
RARB P10826 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1147056 1.00 GCK (0.67) GCKRARGRARARARB
SCHEMBL1261335 0.90 GCK (0.59) GCKRARGRARARARB
SCHEMBL1263205 0.89 GCK (0.71) GCKRARGRARARARB
SCHEMBL1146572 0.88 GCK (0.62) GCKRARG
SCHEMBL13891602 0.88 GCK (0.62) GCKRARG
SCHEMBL1107734 0.87 GCK (0.57) GCKRARGRARARARB
SCHEMBL12858604 0.86 GCK (0.53) GCKRARG
SCHEMBL1107704 0.85 GCK (0.68) GCKRARGRARARARB
SCHEMBL1263158 0.85 GCK (0.55) GCKRARGRARARARB
SCHEMBL1262369 0.84 GCK (0.69) GCKRARGRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016112863-A1 N-SUBSTITUTED-3,5-DISUBSTITUTED BENZAMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF 中国科学院上海药物研究所 2016-07-21 WO disclosed
US-7700640-B2 Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2010-04-20 US disclosed
US-7700640-B2 Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2010-04-20 US disclosed
US-7700640-B2 Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2010-04-20 US disclosed
EP-2048137-A1 Benzamide derivatives and their use as glucokinase activating agents. AstraZeneca AB (SE) 2009-04-15 EP disclosed
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds ASTRAZENECA AB (SE) 2008-08-21 US disclosed
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds ASTRAZENECA AB (SE) 2008-08-21 US disclosed
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds ASTRAZENECA AB (SE) 2008-08-21 US disclosed
EP-1802570-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS AstraZeneca AB (SE) 2007-07-04 EP disclosed
WO-2006040527-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds PAH, MAOB, TYR GCK 1415/4885RARG 2452/4885RARA 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.